|
Valoración de DCF de Aptevo Therapeutics Inc. (APVO)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Aptevo Therapeutics Inc. (APVO) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de Aptevo Therapeutics Inc. (APVO)! Explore datos financieros reales, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de Aptevo Therapeutics Inc. (APVO).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3 | 12.3 | 3.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 185.26 | -74.67 | -100 | 0 | -18.67 | -18.67 | -18.67 | -18.67 | -18.67 |
| EBITDA | -26.1 | -20.3 | -27.7 | -28.3 | -24.6 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -605.43 | -164.79 | -890.82 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | 1.4 | 1.1 | .9 | .6 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 32.63 | 9.31 | 28.93 | 100 | 100 | 54.17 | 54.17 | 54.17 | 54.17 | 54.17 |
| EBIT | -27.5 | -21.4 | -28.6 | -28.9 | -24.6 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -638.06 | -174.1 | -919.75 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 40.0 | 45.0 | 22.6 | 16.9 | 8.7 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.4 | 3.7 | 2.5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 54.98 | 29.81 | 80.28 | 100 | 100 | 73.01 | 73.01 | 73.01 | 73.01 | 73.01 |
| Inventories | 4.8 | 3.1 | 1.6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 111 | 25.07 | 50.45 | 100 | 100 | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 |
| Accounts Payable | 5.6 | 3.5 | 3.5 | 4.0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 129.57 | 28.16 | 112.36 | 100 | 100 | 85.63 | 85.63 | 85.63 | 85.63 | 85.63 |
| Capital Expenditure | -.1 | -.7 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.04 | -5.8 | -0.93128 | 100 | 100 | -1.75 | -1.75 | -1.75 | -1.75 | -1.75 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -16.4 | -19.9 | -174.2 | -27.0 | -24.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -16.7 | -21.2 | -170.7 | -21.8 | -28.6 | .0 | .0 | .0 | .0 | .0 |
| WACC, % | 7.29 | 8.37 | 8.61 | 8.39 | 8.61 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | 4 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | 14.33 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real APVO financials.
- Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Quickly see how your inputs affect Aptevo’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Customizable Financial Metrics: Adjust essential inputs such as revenue projections, R&D spending, and operational costs.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics with ease.
- High-Precision Accuracy: Utilizes Aptevo's actual financial data for dependable valuation results.
- Effortless Scenario Testing: Explore various assumptions and analyze results without hassle.
- Efficiency Booster: Remove the necessity of constructing intricate valuation models from the ground up.
How It Works
- 1. Download the Template: Obtain and open the Excel file featuring Aptevo Therapeutics Inc.'s (APVO) preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation insights to enhance your decision-making process.
Why Choose This Calculator for Aptevo Therapeutics Inc. (APVO)?
- Accurate Data: Utilize real Aptevo financials for trustworthy valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants focusing on biotechnology.
- User-Friendly: An intuitive design and clear instructions ensure accessibility for all users.
Who Should Use Aptevo Therapeutics Inc. (APVO)?
- Investors: Make informed investment choices with insights into innovative therapeutic solutions.
- Healthcare Analysts: Streamline your analysis with comprehensive data on drug development and market potential.
- Consultants: Easily customize reports for clients interested in biotechnology advancements.
- Biotech Enthusiasts: Expand your knowledge of therapeutic innovations and their impact on patient care.
- Educators and Students: Utilize it as a valuable resource in biotechnology and pharmaceutical studies.
What the Template Contains
- Pre-Filled DCF Model: Aptevo Therapeutics Inc.'s (APVO) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Aptevo's profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.